![Wlodzimierz Stepkowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wlodzimierz Stepkowski
Direttore/Membro del Consiglio presso CANNABIS POLAND S.A.
Posizioni attive di Wlodzimierz Stepkowski
Società | Posizione | Inizio | Fine |
---|---|---|---|
CANNABIS POLAND S.A. | Direttore/Membro del Consiglio | - | - |
GARIN S.A. | Corporate Officer/Principal | 01/04/2015 | - |
ERNE VENTURES SA | Corporate Officer/Principal | 01/04/2015 | - |
POLSKA GRUPA MILITARNA SPÓLKA AKCYJNA | Direttore/Membro del Consiglio | - | - |
HEMP & HEALTH S.A. | Direttore/Membro del Consiglio | - | - |
Telehorse Sp zoo
![]() Telehorse Sp zoo Packaged SoftwareTechnology Services Telehorse Sp zoo engages in the design of software. The company was founded on June 18, 2013 and is headquartered in Warsaw, Poland. | Direttore/Membro del Consiglio | - | - |
Super Liquid SA | Direttore/Membro del Consiglio | 01/01/2017 | - |
Storia della carriera di Wlodzimierz Stepkowski
Precedenti posizioni note di Wlodzimierz Stepkowski
Società | Posizione | Inizio | Fine |
---|
Statistiche
Distribuzione geografica
Polonia | 8 |
Posizioni
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Settori
Technology Services | 3 |
Health Technology | 2 |
Consumer Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
CANNABIS POLAND S.A. | Health Technology |
GARIN S.A. | Consumer Durables |
POLSKA GRUPA MILITARNA SPÓLKA AKCYJNA | Technology Services |
HEMP & HEALTH S.A. | Commercial Services |
Aziende private | 3 |
---|---|
Telehorse Sp zoo
![]() Telehorse Sp zoo Packaged SoftwareTechnology Services Telehorse Sp zoo engages in the design of software. The company was founded on June 18, 2013 and is headquartered in Warsaw, Poland. | Technology Services |
Erne Ventures SA
![]() Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
Super Liquid SA |